InsiderTrades.com logo
Trump or Kamala? It may come down to this strange twist…
From Porter & Company   |   Ad
Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? To uncover the full story and learn how you can potentially profit from it...
watch my new documentary here.
Carl Dambkowski net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Carl Dambkowski Biography and Net Worth

Insider of Apogee Therapeutics
Carl Dambkowski, M.D., has served as Chief Medical Officer since September 2022. He also serves on the Board of Oruka Therapeutics, Inc. Prior to joining Apogee, Dr. Dambkowski served as a strategic and clinical leader for a variety of companies. He was part of the core teams that brought TRUSELTIQ (infigratinib) and NULIBRY (fosdenopterin) through regulatory review and FDA approval at QED Therapeutics and Origin Biosciences. He also served as an Associate at McKinsey & Company, where he advised biotech and pharmaceutical companies across the world on a range of research and development activities and co-founded Novonate, Inc., a private medical device company focused on building life-saving devices for neonates. Dr. Dambkowski trained as a physician at Stanford University, where he received his M.D. with a concentration in bioengineering. He also holds an M.A. from Columbia University and a B.A. from Stanford University. The father of two and avid runner, he has run a sub 6-minute mile while pushing his daughter in a stroller.

What is Carl Dambkowski's net worth?

The estimated net worth of Carl Dambkowski is at least $14.10 million as of October 2nd, 2024. Dr. Dambkowski owns 274,128 shares of Apogee Therapeutics stock worth more than $14,098,403 as of October 24th. This net worth estimate does not reflect any other assets that Dr. Dambkowski may own. Additionally, Dr. Dambkowski receives an annual salary of $870,830.00 as Insider at Apogee Therapeutics. Learn More about Carl Dambkowski's net worth.

How old is Carl Dambkowski?

Dr. Dambkowski is currently 38 years old. There are 5 older executives and no younger executives at Apogee Therapeutics. The oldest executive at Apogee Therapeutics is Dr. Rebecca Dabora Ph.D., Chief Development Officer, who is 64 years old. Learn More on Carl Dambkowski's age.

What is Carl Dambkowski's salary?

As the Insider of Apogee Therapeutics, Inc., Dr. Dambkowski earns $870,830.00 per year. The highest earning executive at Apogee Therapeutics is Dr. Michael Thomas Henderson M.D., CEO & Director, who commands a salary of $1,170,000.00 per year. Learn More on Carl Dambkowski's salary.

How do I contact Carl Dambkowski?

The corporate mailing address for Dr. Dambkowski and other Apogee Therapeutics executives is 221 Crescent Street, Building 17 Suite 102b, Waltham, MA 02453, United States. Apogee Therapeutics can also be reached via phone at 650-394-5230 and via email at [email protected]. Learn More on Carl Dambkowski's contact information.

Has Carl Dambkowski been buying or selling shares of Apogee Therapeutics?

In the last ninety days, Carl Dambkowski has sold $374,972.90 of Apogee Therapeutics stock. Most recently, Carl Dambkowski sold 6,665 shares of the business's stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $56.26, for a transaction totalling $374,972.90. Following the completion of the sale, the insider now directly owns 274,128 shares of the company's stock, valued at $15,422,441.28. Learn More on Carl Dambkowski's trading history.

Who are Apogee Therapeutics' active insiders?

Apogee Therapeutics' insider roster includes Carl Dambkowski (Insider), Jane Henderson (CFO), and Michael Henderson (CEO). Learn More on Apogee Therapeutics' active insiders.

Are insiders buying or selling shares of Apogee Therapeutics?

In the last year, insiders at the sold shares 9 times. They sold a total of 167,660 shares worth more than $7,842,946.75. The most recent insider tranaction occured on October, 2nd when insider Carl Dambkowski sold 6,665 shares worth more than $374,972.90. Insiders at Apogee Therapeutics own 36.1% of the company. Learn More about insider trades at Apogee Therapeutics.

Information on this page was last updated on 10/2/2024.

Carl Dambkowski Insider Trading History at Apogee Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/2/2024Sell6,665$56.26$374,972.90274,128View SEC Filing Icon  
9/4/2024Sell6,665$47.56$316,987.40280,793View SEC Filing Icon  
8/7/2024Sell7,335$40.67$298,314.45287,458View SEC Filing Icon  
7/3/2024Sell5,995$37.60$225,412.00294,793View SEC Filing Icon  
See Full Table

Carl Dambkowski Buying and Selling Activity at Apogee Therapeutics

This chart shows Carl Dambkowski's buying and selling at Apogee Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apogee Therapeutics Company Overview

Apogee Therapeutics logo
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $51.43
Low: $50.93
High: $52.23

50 Day Range

MA: $52.40
Low: $45.25
High: $59.92

2 Week Range

Now: $51.43
Low: $14.19
High: $72.29

Volume

198,032 shs

Average Volume

503,497 shs

Market Capitalization

$3.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.75
Trump or Kamala? It may come down to this strange twist…
From Porter & Company   |   Ad
Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? To uncover the full story and learn how you can potentially profit from it...
watch my new documentary here.